Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Neurogastroenterol Motil. 2020 Jan 20;32(4):e13779. doi: 10.1111/nmo.13779

Table 4. Distribution of symptoms and extraintestinal complications among DM patients.

Feature Normal, n (%)
(N=152)
Rapid, n (%)
(N=27)
Functional dyspepsia 45 (30%) 7 (26%)
Nausea and/or vomiting 62 (41%) 12 (44%)
Gastroesophageal reflux and/or atypical chest pain 16 (11%) 1 (4%)
Abdominal Pain 7 (5%) 4 (3%)
Constipation 71 (47%) 12 (44%)
Diarrhea* 40 (26%) 13 (48%)
Weight loss* 43 (28%) 1 (4%)
Extraintestinal complications
None 48 (32%) 10 (37%)
One 54 (36%) 9 (33%)
Two 38 (25%) 6 (22%)
Three 12 (8%) 2 (7%)
Peripheral neuropathya 66 (43%) 9 (33%)
Autonomic neuropathy 21 (14%) 4 (15%)
Retinopathya 20 (13%) 4 (15%)
Nephropathya 79 (52%) 14 (52%)
Proteinuriaa 16 (11%) 3 (19%)
Renal insufficiencya 30 (11%) 6 (11%)
Proteinuria and renal insufficiency 7 (5%) 2 (7%)
Hypertension 53 (35%) 6 (22%)
Coronary artery diseasea 23 (15%) 6 (22%)
Peripheral vascular disease 10 (7%) 3 (11%)
*

P<0.05 for univariate associations among groups

a

Values for peripheral neuropathy, retinopathy, proteinuria, renal insufficiency and coronary artery disease were missing in 10, 34, 62, 19 and 10 patients respectively